Company Filing History:
Years Active: 2022
Title: Zhijun Li: Innovator in Cancer Treatment
Introduction
Zhijun Li is a prominent inventor based in Bala Cynwyd, Pennsylvania. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic polypeptides.
Latest Patents
Zhijun Li holds a patent for "BRAF-based polypeptides for treatment of cancer." This invention provides a polypeptide derived from the dimer interface of BRAF, which is useful for treating various types of cancers. In certain embodiments, the polypeptide can be used to treat, prevent, and/or ameliorate cancers such as lung cancer.
Career Highlights
Zhijun Li is affiliated with the University of the Sciences, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential impact on cancer treatment methodologies.
Collaborations
Zhijun Li collaborates with notable colleagues, including Zhihong Wang and Amber Gunderwala, contributing to a dynamic research environment focused on innovative solutions in healthcare.
Conclusion
Zhijun Li's contributions to cancer treatment through his patented polypeptides highlight his role as an influential inventor in the medical field. His ongoing work promises to enhance therapeutic options for patients battling cancer.